PD-1

Fosun
Favicon Fierce Pharma

Fosun Pharma plots global push, fueled by Alzheimer’s deals

Compared with vying for a slice of the immensely crowded oncology space, Fosun Pharma hopes to gain an edge by taking on higher-risk CNS diseases.
Angus Liu Jun 25, 2026 7:00pm
Person throwing piece of paper into full waste bin
Favicon Fierce Pharma

Nature retracts provocative PD-1 time-of-day study

Jun 24, 2026 11:00am
Golfer devastated after just barely missing a putt

AnaptysBio abandons rosnilimab for UC after phase 2 fail

Nov 10, 2025 10:05am
Akeso
Favicon Fierce Pharma

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am
Gut stomach

Gilead, Arcus keep TIGIT dream alive with 27-month OS data

Oct 13, 2025 7:05am
White arrow on a road pointing to the rising sun

Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

Apr 28, 2025 7:25am